The AbStats Acoustic Gastro-Intestinal Surveillance (AGIS) biosensor can predict with over 80% certainty whether a patient will develop postoperative ileus, according to results of a clinical study presented in a plenary session of Digestive Disease Week 2015 (DDW).
In a multicenter study, AbStats co-investigator Dr. Marc Kaneshiro and his team at Cedars-Sinai Medical Center in Los Angeles used the AGIS biosensor on 28 patients before and after they had abdominal surgery.
“We previously found that a disposable, non-invasive AGIS biosensor distinguishes healthy controls from patients recovering from abdominal surgery. Here we tested whether AGIS can prospectively predict which patients will develop POI in a multicenter study.”
For more information read the abstract of the research presented at DDW.